Consolidation and Differentiation: Key Drivers of Change in the Global Pharmaceutical Manufacturing Industry
By Cynthia Tso; Jansen Jacob
Pharma Deals Review: Vol 2012 Issue 6 (Table of Contents)
Published: 19 Jun-2012
DOI: 10.3833/pdr.v2012.i6.1756 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
Policy-driven changes in healthcare spending and the growing significance of generic competition are acting in tandem to force pharmaceutical companies to adopt more cost-effective manufacturing strategies resulting in an upsurge in the level of M&A activity in the industry as drugmakers consolidate to reduce costs, diversify product portfolios and expand geographic footprints. This whitepaper provides an overview of the pharmaceutical manufacturing landscape with a special focus on generics and biopharmaceuticals. PharmaVentures will also share unique insight gained from the divestment of manufacturing operations for some of the world’s leading pharmaceutical companies.
Copyright: © IQVIA 2018
RSS